Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial.
- 2012-02
- RCT
- Pharmacological Research 65(2)
- M. Gil-Campos
- M. A. López
- M. V. Rodríguez-Benítez
- J. Romero
- I. Roncero
- Mª Dolores Linares
- J. Maldonado
- E. López-Huertas
- R. Berwind
- K. Ritzenthaler
- V. Navas
- C. Sierra
- Lluis Sempere
- A. Geerlings
- J. Maldonado-Lobón
- A. Valero
- F. Lara‐Villoslada
- M. Olivares
- PubMed: 22155106
- DOI: 10.1016/j.phrs.2011.11.016
- High evidence
- Highly Cited
The incidence rate of gastrointestinal infections in infants of the control group was 3 times higher than in the probiotic group (p=0.018).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes